News
General practitioners (GPs) and nurse practitioners will be able to start medical treatment for adults with ADHD, following decisions by Medsafe and Pharmac.
Consultation on the Code of Practice for Irradiating Apparatus: ORS C10 2020 - Ministry of Health NZ
The Director for Radiation Safety (the Director) intends to review the Code of Practice for Irradiating Apparatus: ORS C10 2020 (ORS C10 2020). The review will be conducted in accordance with section ...
Background Under section 53 of the Residential Care and Disability Support Services Act 2018, the Director-General of Health has determined the maximum contribution that applies in each region for ...
This rest home has been audited against the Health and Disability Services Standards. During the last audit, the auditors identified some areas for improvement. Issues from their last audit are listed ...
Medsafe has given a New Zealand psychiatrist approval to prescribe medicinal psilocybin for treating treatment-resistant depression.
As a department of the public service, the Ministry of Health – Manatū Hauora has a responsibility to contribute to the Crown meeting its obligations under Te Tiriti o Waitangi. This statement ...
Our climate is changing. These changes are affecting what we value most in our lives, including our health and wellbeing. This first Health National Adaptation Plan (HNAP) is an important step towards ...
Trends in daily smoking and daily vaping vary by ethnic group Daily smoking has declined in all ethnic groups from 2011/12 to 2023/24, although trends have been more variable in Asian and Pacific ...
This position statement accompanies the release of an evidence brief which examines the safety and long-term impacts of puberty blockers when used in the context of gender-affirming care. This ...
The Government is reviewing health workforce regulation to improve New Zealanders’ timely, quality access to healthcare. We have an opportunity to put patients at the centre, modernise and streamline ...
The consultation on safety measures for the use of puberty blockers in young people with gender-related health needs closed on 20 January 2025. We will now consider submissions.BackgroundThe ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results